Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience / Olivera, P; Thiriet, L; Luc, A; Baumann, C; Danese, S; Peyrin-Biroulet, L. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - 23:6(2017), pp. 976-985. [10.1097/MIB.0000000000001072]
Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience
Danese S;
2017-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.